Peng Luan

2.3k total citations · 1 hit paper
30 papers, 1.8k citations indexed

About

Peng Luan is a scholar working on Molecular Biology, Hematology and Cell Biology. According to data from OpenAlex, Peng Luan has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Hematology and 5 papers in Cell Biology. Recurrent topics in Peng Luan's work include Cellular transport and secretion (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Iron Metabolism and Disorders (4 papers). Peng Luan is often cited by papers focused on Cellular transport and secretion (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Iron Metabolism and Disorders (4 papers). Peng Luan collaborates with scholars based in United States, China and Vietnam. Peng Luan's co-authors include M. Gläser, Stanley J. Hollenbach, Uma Sinha, Keith Abe, Pamela B. Conley, Genmin Lu, David R. Phillips, Francis DeGuzman, Athiwat Hutchaleelaha and Mayuko Inagaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Peng Luan

30 papers receiving 1.8k citations

Hit Papers

A specific antidote for reversal of anticoagulation by di... 2013 2026 2017 2021 2013 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Luan United States 21 718 487 370 297 282 30 1.8k
Dennis B. Rylatt Australia 21 1.5k 2.0× 88 0.2× 49 0.1× 309 1.0× 137 0.5× 32 2.3k
Marek Duszyk Canada 25 701 1.0× 106 0.2× 27 0.1× 91 0.3× 148 0.5× 61 1.6k
Hiroshi Masumoto Japan 25 2.0k 2.8× 162 0.3× 57 0.2× 376 1.3× 21 0.1× 73 2.8k
G. D. Hunter United States 24 1.2k 1.6× 166 0.3× 29 0.1× 109 0.4× 434 1.5× 50 2.2k
Rodger A. Allen United States 26 1.2k 1.6× 71 0.1× 28 0.1× 221 0.7× 165 0.6× 43 2.3k
Yuichi Takakuwa Japan 31 1.4k 1.9× 99 0.2× 21 0.1× 577 1.9× 244 0.9× 97 2.9k
M. Kyle Hadden United States 23 1.3k 1.8× 44 0.1× 26 0.1× 140 0.5× 108 0.4× 77 1.8k
George B. Segel United States 25 908 1.3× 53 0.1× 17 0.0× 146 0.5× 373 1.3× 80 2.0k
Mary T. Walsh United States 24 944 1.3× 104 0.2× 16 0.0× 179 0.6× 62 0.2× 43 1.8k
Cristian Ruse United States 22 2.3k 3.2× 141 0.3× 16 0.0× 275 0.9× 24 0.1× 41 2.9k

Countries citing papers authored by Peng Luan

Since Specialization
Citations

This map shows the geographic impact of Peng Luan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Luan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Luan more than expected).

Fields of papers citing papers by Peng Luan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Luan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Luan. The network helps show where Peng Luan may publish in the future.

Co-authorship network of co-authors of Peng Luan

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Luan. A scholar is included among the top collaborators of Peng Luan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Luan. Peng Luan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ellwanger, Daniel C., Shoutang Wang, Simone Brioschi, et al.. (2021). Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer’s disease. Proceedings of the National Academy of Sciences. 118(3). 96 indexed citations
3.
Li, Bing, Ashley E. Fouts, Katharina Stengel, et al.. (2014). In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation. mAbs. 6(2). 437–445. 18 indexed citations
4.
Yang, Jane, Mike Frohn, Wei Wang, et al.. (2014). Impact of Glycation on Antibody Clearance. The AAPS Journal. 17(1). 237–244. 14 indexed citations
5.
Lu, Genmin, Francis DeGuzman, Stanley J. Hollenbach, et al.. (2013). A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nature Medicine. 19(4). 446–451. 533 indexed citations breakdown →
6.
Luan, Peng, Yimin Jiang, W. M. Chan, et al.. (2013). Long Term Ketamine and Ketamine Plus Alcohol Toxicity - What can we Learn from Animal Models?. Mini-Reviews in Medicinal Chemistry. 13(2). 273–279. 22 indexed citations
7.
Phương, Nguyễn Thị Minh, et al.. (2012). Assessment of the immunogenicity and safety of Quinvaxem® (DTwP-HepB- Hib) against diphtheria, pertussis, tetanus, hepatitis B and diseases caused by H. influenzae among healthy Vietnamese children. International Journal of Infectious Diseases. 16. e304–e305. 1 indexed citations
8.
Lu, Genmin, Francis DeGuzman, Stanley J. Hollenbach, et al.. (2010). Abstract 12420: Reversal of Low Molecular Weight Heparin and Fondaparinux by a Recombinant Antidote (r-Antidote, PRT064445). Circulation. 122. 8 indexed citations
9.
Köster, Hubert, Daniel P. Little, Peng Luan, et al.. (2007). Capture Compound Mass Spectrometry: A Technology for the Investigation of Small Molecule Protein Interactions. Assay and Drug Development Technologies. 5(3). 381–390. 62 indexed citations
10.
Chen, Huaxian, Joy L. Kovar, Sean E. Sissons, et al.. (2004). A cell-based immunocytochemical assay for monitoring kinase signaling pathways and drug efficacy. Analytical Biochemistry. 338(1). 136–142. 66 indexed citations
11.
Huang, Mingdong, Jacques T. Weissman, Sophie Béraud-Dufour, et al.. (2001). Crystal structure of Sar1-GDP at 1.7 A resolution and the role of the NH2 terminus in ER export. The Journal of Cell Biology. 155(6). 937–948. 119 indexed citations
12.
Luan, Peng, A. Heine, Bryan D. Moyer, et al.. (2000). A New Functional Domain of Guanine Nucleotide Dissociation Inhibitor (α‐GDI) Involved in Rab Recycling. Traffic. 1(3). 270–281. 31 indexed citations
13.
Luan, Peng, Elena Aréchaga-Ocampo, Gautam Sarath, Raúl Arredondo‐Peter, & Robert V. Klucas. (2000). Analysis of a ferric leghemoglobin reductase from cowpea (Vigna unguiculata) root nodules. Plant Science. 154(2). 161–170. 9 indexed citations
14.
Luan, Peng, William E. Balch, Scott D. Emr, & Christopher G. Burd. (1999). Molecular Dissection of Guanine Nucleotide Dissociation Inhibitor Function in Vivo. Journal of Biological Chemistry. 274(21). 14806–14817. 47 indexed citations
16.
Luan, Peng, et al.. (1998). Processing of viral envelope glycoprotein by the endomannosidase pathway: Evaluation of host cell specificity. Glycobiology. 8(7). 725–730. 39 indexed citations
17.
Wu, Shih-Kwang, et al.. (1998). Molecular Role for the Rab Binding Platform of Guanine Nucleotide Dissociation Inhibitor in Endoplasmic Reticulum to Golgi Transport. Journal of Biological Chemistry. 273(41). 26931–26938. 29 indexed citations
18.
Luan, Peng, Li Yang, & Michael Gläser. (1995). Formation of membrane domains created during the budding of vesicular stomatitis virus. A model for selective lipid and protein sorting in biological membranes. Biochemistry. 34(31). 9874–9883. 56 indexed citations
19.
Zhou, Ye, et al.. (1994). Chiral derivatizing reagents for drug enantiomers bearing hydroxyl groups. Journal of Chromatography B Biomedical Sciences and Applications. 659(1-2). 109–126. 24 indexed citations
20.
Luan, Peng & Michael Gläser. (1994). Formation of membrane domains by the envelope proteins of vesicular stomatitis virus. Biochemistry. 33(15). 4483–4489. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026